Sort
30,917 grants matching “tumor microenvironment”
Adenovirus Replication-Competent Anti-Cancer Vector
$359,756Virrx, Inc · R42 · FY2003 · CA
Roles of proinflammatory chemokines linking obesity and breast cancer
$359,732Deok-Soo Son · Meharry Medical College · SC1 · FY2015 · CA
Targeted inhibition in stromal TGFβ activity in pancreatic cancer
$359,711Rolf A Brekken · Ut Southwestern Medical Center · R01 · FY2021 · CA
The role of GPSM3 in tumor-promoting emergency myelopoiesis
$359,710Bin Zhang · Northwestern University At Chicago · R01 · FY2017 · CA
Ovarian Cancer: Mechanisms of Neuroendocrine Regulation
$359,706Anil K Sood · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · CA
Ultrasonic Elasticity Imaging of the Breast
$359,650Michael F Insana · University Of Illinois At Urbana-Champaign · R01 · FY2008 · CA
Targeting microtubule stabilization to reduce breast tumor metastasis
$359,599Stuart S Martin · University Of Maryland Baltimore · R01 · FY2023 · CA
Targeting microtubule stabilization to reduce breast tumor metastasis
$359,599Stuart S Martin · University Of Maryland Baltimore · R01 · FY2022 · CA
Regulatory Immune Cell Networks in Cancer
$359,577Thorsten Roman Mempel · Massachusetts General Hospital · R01 · FY2010 · CA
Contributions of FGFR-Mediated Tumor-Stromal Interactions to Breast Cancer Growth and Progression
$359,542Kathryn L Schwertfeger · University Of Minnesota · R01 · FY2024 · CA
A Cobalt Porphyrin Nanoliposome Adjuvant for MHC-I-Restricted Cancer Peptide Vaccines
$359,516Jonathan F Lovell · State University Of New York At Buffalo · R01 · FY2024 · CA
Novel tumorigenic mechanisms of the LKB1 tumor suppressor
$359,457Diego H Castrillon · Ut Southwestern Medical Center · R01 · FY2019 · CA
Analytical determination of biomarkers for diagnosis of breast cancer metastatic progression
$359,457Venu Raman · Johns Hopkins University · R01 · FY2019 · CA
Multiscale Image-based Modeling of Antiangiogenic Resistance in Breast Cancer
$359,457Arvind P Pathak · Johns Hopkins University · R01 · FY2019 · CA
Nanoprobe-enabled Delineation of Tumor Margins for Improved Surgical Therapy
$359,457Jinming Gao · Ut Southwestern Medical Center · R01 · FY2019 · CA
Jagged1-dependent tumor-stromal interactions in bone metastasis
$359,457Yibin Kang · Princeton University · R01 · FY2019 · CA
Paradoxical roles of tumor lymphangiogenesis on tumor immunity and implications for immunotherapy - Resubmission 01
$359,457Melody A Swartz · University Of Chicago · R01 · FY2019 · CA
Framing Therapeutic Opportunities in Tumor-Activated Gametogenic Programs
$359,457Angelique Wright Whitehurst · Ut Southwestern Medical Center · R01 · FY2019 · CA
Efficient Delivery of Plasmid DNA to Achieve Appropriate Transgene Expression
$359,454Richard Heller · Old Dominion University · R01 · FY2018 · CA
Innate Immune Therapy for B-Cell Malignancies
$359,411John C Byrd · Ohio State University · P01 · FY2013 · CA
MUC13 Mucin in Colorectal Cancer Health Disparity
$359,410Subhash C. Chauhan · University Of Tennessee Health Sci Ctr · R01 · FY2016 · CA
Characterization and Enhancement of Anti-Tumor Immune Responses in Head and Neck Cancer
$359,407Clint Allen · National Institute On Deafness And Other Communication Disorders · ZIA · FY2015 · DC
FOXD3 up-regulation and ERBB3 signaling as an adaptive response to BRAF inhibitors in melanoma
$359,385Andrew E Aplin · Thomas Jefferson University · R01 · FY2019 · CA
Molecular Epidemiologic Study of Breast Cancer
$359,363Wei Zheng · Vanderbilt University · R01 · FY2008 · CA
The Role of T Cell Avidity in Determining Tumor Immunity and Autoimmunity
$359,316Arthur Hurwitz · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA